MoneyWorks4Me

Cipla informs about outcome of circular resolution

09 Jan 2017 Evaluate

Cipla has informed that the Board of Directors of the Company through a circular resolution on January 09, 2017 has appointed Peter Lankau as an Additional Director of the Company with effect from January 10, 2017 to hold office as an Independent Director of the Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..